arrow
M

Mengfan Wu

hefei university of technology
H指数:16
被引数:727

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Epigenetic reprogramming via EZH2 inhibition rescues fibroadipose pathogenesis in secondary lymphedema through activating PPARγ signaling

通过EZH2抑制进行的表观遗传重编程,通过激活PPARγ信号通路,挽救了继发性淋巴水肿中的纤维脂肪病理性改变。

2025-10-010
OAAI
Adipocyte cell therapy targeting bone morphogenetic protein signaling alleviates fibroadipose tissue deposition in secondary lymphedema

靶向骨形态发生蛋白信号通路的脂肪细胞疗法可减轻继发性淋巴水肿中的纤维脂肪组织沉积

2025-09-220
PRE
PPARγ agonist treatment reduces fibroadipose tissue in secondary lymphedema by exhausting fibroadipogenic PDGFRα plus mesenchymal cells
2023-12-220
OA
Racial disparities in surgical outcomes after mastectomy in 223 000 female breast cancer patients: a retrospective cohort study

223 000名女性乳腺癌患者乳房切除术后手术结果的种族差异: 一项回顾性队列研究

2023-12-0510
OAAI
Impact of sarcopenia on outcomes in surgical patients: a systematic review and meta-analysis

肌肉减少症对手术患者预后的影响: 系统回顾和荟萃分析

2023-09-0816
OAAI